518344-25-7

Upstream product

• 87769-63-9 5-amino-6-phenyl-1,6-dihydropyridazin-3(2H)-one 
• 89868-06-4 4-amino-6-phenyl-3(2H)-pyridazinone 
• 350578-58-4 C₂₀H₂₄N₆O₅ 
• 350578-56-2 C₂₀H₂₄BrN₃O₅ 
• 350578-55-1 4-Amino-5-bromo-6-phenyl-3(2H)-pyridazinone 
• 350578-59-5 C₂₀H₂₆N₄O₅ 
• 881993-34-6 C₂₅H₃₂BrN₃O₇ 

Downstream Products

• 350578-61-9 (5-amino-6-phenyl-pyridazin-4-yl)-phosphoramidic acid diethyl ester 
• 350578-66-4 3-tert-butyl-8-phenyl-1H-pyrazino[2,3-d]pyridazin-2-one 
• 350578-65-3 3-(Furan-2-yl)-8-phenyl-1H-pyrazino[2.3-d]pyridazin-2-one 
• 350578-68-6 8-Phenyl-3-(2-thienyl)-1H-pyrazino[2,3-d]pyridazin-2-one 
• 350578-67-5 3,8-Diphenyl-1H-pyrazino[2,3-d]pyridazin-2-one 

Relevant academic research and scientific papers

Synthesis of pyrido[2,3-d]pyridazines and pyrazino[2,3-d]-pyridazines-novel classes of GABAA receptor benzodiazepine binding site ligands

Novel syntheses of 2,3,8-trisubstituted pyrido[2,3-d]pyridazines and 2,3,5-trisubstituted pyrazino[2,3-d]pyridazines are described. Two complementary routes to pyrido[2,3-d]pyridazines were developed, the first of which began by constructing the pyridine

Pyridazines. Part 31: synthesis and antiplatelet activity of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones.

This paper describes the synthesis and the antiplatelet activity of a series of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones. Some of these compounds show a dose-dependent activity and were found to be more active than their 5-substituted analogues.